There are restrictions on commercial use for articles published under CC BY-NC.is committed to keeping research articles open access.A number of institutions have open access institutional memberships with BMJ (the publishing group), which either cover the whole cost of open access publishing for authors at participating institutions or allows authors to receive a discount on the article processing charge.For a list of member institutions and their policies on how to receive a discount or to publish free of charge, please visit In accordance with the International Committee of Medical Journal Editors' will not consider reports of clinical trials unless they were registered prospectively before recruitment of any participants.At the early stages of the response to an unusual major event or disease outbreak, however, case series can provide helpful and original preliminary information for clinicians and policy makers.So will consider as research articles case series that are sufficiently informative for clinical and public health practice or policy (preferably internationally) and are compelling, well described, and topical.
Case series lack formal hypotheses and formal study designs that prespecify the sampling criteria and methods, data collection, and analyses.
’s Impact Factor is 20.7 (ISI Web of Science, 2017).
Articles should be submitted as "Research" via our online editorial office.
To support this we ask authors to pay an open access article publishing charge/fee of £3000 (excluding VAT) on acceptance of their paper.
We can offer discounts and waivers for authors who cannot pay.